REFERENCES
- Dudrick S J, Maharaj A R, McKelvey A A. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg. 1999; 23: 570–576
- Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice: A review. Gut. 2001; 49: 2–10, Suppl 4
- Nordenstrom J, Thorne A. Benefits and complications of parenteral nutritional support. Eur J Clin Nutr. 1994; 48: 531–537
- Martinez D, Zibari G, Aultman D, McMillan R, Mancini M C, Rush B M, McDonald J C. The outcome of intestinal fistulae: The Louisiana State University Medical Center–Shreveport experience. Am Surg. 1998; 64: 252–254
- Makhdoom Z A, Komar M J, Still C D. Nutrition and enterocutaneous fistulas. J Clin Gastroenterol. 2000; 31: 195–204
- Gonzalez-Pinto I, Gonzalez E M. Optimising the treatment of upper gastrointestinal fistulae. Gut. 2001; 49: 22–31, (Suppl 4)
- Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Hepatogastroenterology. 2002; 49: 1010–1012
- Hesse U, Ysebaert D, de Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: Clinical data. Gut. 2001; 49: 11–21, (Suppl 4)
- Lloyd D A, Gabe S M, Windsor A C. Nutrition and management of enterocutaneous fistula. Br J Surg. 2006; 93: 1045–1055
- Draus J M, Jr., Huss S A, Harty N J, Cheadle W G, Larson G M. Enterocutaneous fistula: are treatments improving?. Surgery. 2006; 140: 570–576, discussion 576–578
- Hollington P, Mawdsley J, Lim W, Gabe S M, Forbes A, Windsor A J. An 11-year experience of enterocutaneous fistula. Br J Surg. 2004; 91: 1646–1651
- Chamberlain R S, Kaufman H L, Danforth D N. Enterocutaneous fistula in cancer patients: Etiology, management, outcome, and impact on further treatment. Am Surg. 1998; 64: 1204–1211
- Kaur N, Minocha V R, Mundu M. Improving outcome in patients of high output small bowel fistula. Trop Gastroenterol. 2004; 25: 92–95
- Campos A C, Andrade D F, Campos G M, Matias J E, Coelho J C. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am Coll Surg. 1999; 188: 483–490
- Quigley E M, Marsh M N, Shaffer J L, Markin R S. Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993; 104: 286–301
- Salvino R, Ghanta R, Seidner D L, Mascha E, Xu Y, Steiger E. Liver failure is uncommon in adults receiving long-term parenteral nutrition. J Parenter Enteral Nutr. 2006; 30: 202–208
- Luman W, Shaffer J L. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr. 2002; 21: 337–343
- Grau T, Bonet A, Rubio M, Mateo D, Farre M, Acosta J A, Blesa A, Montejo J C, de Lorenzo A G, Mesejo A. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care. 2007; 11: R10
- Abad-Lacruz A, Gonzalez-Huix F, Esteve M, Fernandez-Banares F, Cabre E, Boix J, Acero D, Humbert P, Gassull M A. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: A prospective randomized study of total enteral nutrition vs total parenteral nutrition. J Parenter Enteral Nutr. 1990; 14: 618–621
- Kumpf V J. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006; 21: 279–290
- Franch-Arcas G. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr. 2001; 20: 265–269
- Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri S F. Preoperative serum albumin level as a predictor of operative mortality and morbidity: Results from the National VA Surgical Risk Study. Arch Surg. 1999; 134: 36–42
- Llop J M, Munoz C, Badia M B, Virgili N, Tubau M, Ramon J M, Pita A, Jodar J R. Serum albumin as indicator of clinical evolution in patients on parenteral nutrition. Multivariate study. Clin Nutr. 2001; 20: 77–81